N/A
Completed N=22
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia
Attention Deficit Hyperactivity Disorder · Delayed Sleep Phase Type Circadian Rhythm Sleep Disorder
Source: ClinicalTrials.gov NCT01557595 ↗
Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcomePrimary: Pittsburgh Sleep Quality Index (PSQI) at 2 Weeks After Baseline — 4.54 units on a scale
Summary
Patients with ADHD often report staying up late on the computer, watching TV, or using other electronic devices, all strong emitters of blue light which may be contributing to the delayed sleep onset times seen in some of these patients. Evening use of polarizing glasses which filter out blue light may decrease the contribution of environmental light late at night to delayed bedtime. This is a treatment that Dr. Fargason uses when patients do not want to use sleep medication to help them fall asleep. The purpose of this study is to evaluate the effectiveness of this treatment by use of sleep diaries and sleep questionnaires.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pittsburgh Sleep Quality Index (PSQI) at 2 Weeks After Baseline |
4.54 | — |
Eligibility Criteria
Inclusion Criteria
- 19 years of age and older
- Diagnosis of ADHD and DCRD
- Willingness to sign consent and participate in the study
Exclusion Criteria
- No sleep medication for previous two weeks before screen visit (Can enroll if willing to undergo washout period)
Data sourced from ClinicalTrials.gov (NCT01557595). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.